Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers

Abstract

Loss of heterozygosity (LOH) has been frequently detected at chromosome 7q31 region in human head and neck squamous cell carcinomas (HNSCC) and many other cancers, suggesting the existence of tumor suppressor genes (TSG). We analysed LOH at 7q31 region in 49 HNSCC by using six polymorphic microsatellite markers and found allelic deletion in 48% (22/46) of the informative cases. We detected two preferentially deleted regions, one is around D7S643 and the other around D7S486. When we redefined the map of 7q31 region according to the contiguous sequences, a recently identified gene, ING3, was found in the proximity of D7S643. ING3 protein harbors the PHD domain highly homologous among ING family proteins, in which we previously found mutations in a related gene, ING1. As only one missense mutation of the ING3 gene was found in HNSCC, we examined the expression level. Reverse-transcription-PCR analysis demonstrated decreased or no expression of ING3 mRNA in 50% of primary tumors as compared with that of matched normal samples. Especially, about 63% of tongue and larynx tumors showed the decrease and a tendency of higher mortality was observed in cases with decreased ING3 expression. All these findings suggest a possibility that the ING3 gene functions as a TSG in a subset of HNSCC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Bassam BJ, Caetano-Anolles G, Gresshoff PM . 1991 Anal. Biochem. 196: 80–83

  • Bieche I, Khodja A, Driouch K, Lidereau R . 1997 Clin. Cancer Res. 3: 1009–1016

  • Cowan JM, Beckett MA, Ahmed-Swan S, Weichselbaum RR . 1992 J. Natl. Cancer Inst. 84: 793–797

  • Edelson MI, Scherer SW, Tsui LC, Welch WR, Bell DA, Berkowitz RS, Mok SC . 1997 Oncogene 14: 2979–2984

  • Garkavtsev I, Kazarov A, Gudkov A, Riabowol K . 1996 Nat. Genet. 14: 415–420

  • Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM, Gudkov AV . 1998 Nature 391: 295–298

  • Gunduz M, Ouchida M, Fukushima K, Hanafusa H, Etani T, Nishioka S, Nishizaki K, Shimizu K . 2000 Cancer Res. 60: 3143–3146

  • Hinds PW, Weinberg RA . 1994 Curr. Opin. Genet. Dev. 4: 135–141

  • Hurlstone AFL, Reid G, Reeves JR, Fraser J, Strathdee G, Rahilly M, Parkinson EK, Black DM . 1999 Oncogene 18: 1881–1890

  • Knudson AG . 1993 Proc. Natl. Acad. Sci. USA 90: 10914–10921

  • Kohno T, Takakura S, Yamada T, Okamoto A, Tanaka T, Yokota J . 1999 Cancer Res. 59: 4170–4174

  • Kukita A, Kukita T, Maeda H, Ouchida M, Yatsuki H, Kohashi O . 1999 Blood 94: 1987–1997

  • Latil A, Cussenot O, Fournier G, Baron JC, Lidereau R . 1995 Clin. Cancer Res. 1: 1385–1389

  • Lin JC, Scherer SW, Tougas L, Traverso G, Tsui LC, Andrulis IL, Jothy S, Park M . 1996 Oncogene 13: 2001–2008

  • Loewith R, Meijer M, Lees-Miller S, Riabowol K, Young D . 2000 Mol. Cell. Biol. 20: 3807–3816

  • Nagashima M, Shiseki M, Miura K, Hagiwara K, Linke SP, Pedeux R, Wang XW, Yokota J, Riabowol K, Harris CC . 2001 Proc. Natl. Acad. Sci. USA 98: 9671–9676

  • Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M, Oishi M . 1993 Mol. Cell. Biol. 13: 6036–6043

  • Shimada Y, Saito A, Suzuki M, Takahashi E, Horie M . 1998 Cytogenet. Cell Genet. 83: 232–235

  • Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI . 1997 Oncogene 15: 2727–2733

  • Skowyra D, Zeremski M, Neznanov N, Li M, Choi Y, Uesugi M, Hauser CA, Gu W, Gudkov AV, Qin J . 2001 J. Biol. Chem. 276: 8734–8739

  • Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN, Jenkins RB . 1995 Cancer Res. 55: 4114–4119

  • Tanino M, Matsuo M, Uenaka A, Tsukuda K, Ouchida M, Nakayama E, Shimizu K . 1999 Mol. Carcinog. 26: 286–297

  • Tatarelli C, Linnenbach A, Mimori K, Croce CM . 2000 Genomics 68: 1–12

  • Toyama T, Iwase H, Watson P, Muzik H, Saettler E, Magliocco A, DiFrancesco L, Forsyth P, Garkavtsev I, Kobayashi S, Riabowol K . 1999 Oncogene 18: 5187–5193

  • Wang XL, Uzawa K, Miyakawa A, Shiiba M, Watanabe T, Sato T, Yokoe H, Tanizawa H . 1998 Int. J. Cancer 75: 671–674

  • Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, Giancotti FG . 1996 Cell 87: 733–743

  • Zenklusen JC, Thompson JC, Klein-Szanto AJP, Conti CJ . 1995 Cancer Res. 55: 1347–1350

  • Zenklusen JC, Oshimura M, Barrett JC, Conti CJ . 1994 Oncogene 9: 2817–2825

  • Zenklusen JC, Hodges LC, Lacava M, Green ED, Conti CJ . 2000 Oncogene 19: 1729–1733

  • Zenklusen JC, Conti CJ, Green ED . 2001 Nat. Genet. 27: 392–398

  • Zeremski M, Hill JE, Kwek SS, Grigorian IA, Gurova KV, Garkavtsev IV, Diatchenko L, Koonin EV, Gudkov AV . 1999 J. Biol. Chem. 274: 32172–32181

  • Zhang JS, Nelson M, Mciver B, Hay ID, Goellner JR, Grant CS, Eberhardt NL, Smith DI . 1998 Oncogene 17: 789–793

Download references

Acknowledgements

We would like to thank cell depositors, Drs M Urade, T Okabe and M Miyake for their kind approval for the cell distribution through cell bank. We thank T Fujiwara, A Sakai and H Hanafusa for technical support and the surgeons in the Department of Otolaryngology of our Medical School for providing fresh specimens. This work was supported by grants-in-aids from the Ministry of Education, Science, Sports and Culture and from the Ministry of Health and Welfare of Japan to K Shimizu.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenji Shimizu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gunduz, M., Ouchida, M., Fukushima, K. et al. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Oncogene 21, 4462–4470 (2002). https://doi.org/10.1038/sj.onc.1205540

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205540

Keywords

This article is cited by

Search

Quick links